IVF
INVO Fertility, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$0.99
+0.16%Aug 17, 2026, 23:30 UTC
INVO Fertility Inc reported its Q2 2026 earnings, with revenue rising 17% year-over-year to $2.18 million and improved operating results.
Source:Jul 24, 2026, 00:00 UTC
INVO Fertility, Inc. entered into a Common Stock Purchase Agreement with an investor for a committed equity line of up to $50 million, with an initial commitment of $15 million.
Jun 25, 2026, 00:00 UTC
INVO Fertility, Inc. acquired 100% of HRCFG membership interests from sellers Karen Hammond, Lisa Ray, and Nicholas Cataldo for a total purchase price of $175,001.
Jun 2, 2026, 20:50 UTC
INVO Fertility received a delinquency notice from Nasdaq for late filing of its quarterly report on Form 10-Q.
Jun 2, 2026, 00:00 UTC
INVO Fertility, Inc. reported its fiscal year 2025 financial results, with total revenue of $6,841,250 and a net loss of $23,323,054.